I think Nuvaring was accepted around 20 March 2018, so we expect the FDA review by 20 January 2019. Not long now... I think the market may have been spooked by CEO commentary that they are handling a number of review questions by FDA re Nuvaring application, but this is very standard for most applications. I think it is coming soon and if that doesn't put a rocket under the SP nothing will!
$2 here we come...., page-470
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.82 |
Change
-0.060(1.23%) |
Mkt cap ! $413.4M | |||
| Open | High | Low | Value | Volume |
| $5.01 | $5.02 | $4.79 | $285.8K | 59.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 679 | $4.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.83 | 237 | 3 |
View Market Depth
| Last trade - 12.07pm 15/11/2024 (20 minute delay) ? |
| MYX (ASX) Chart |